logo

For the Inventor, By the Inventor

Culver City, CA, United States of America

Nantomics, LLC


USPTO Granted Patents = 66



Forward Citations = 147

Loading Chart...
Loading Chart...

40 inventors (with patents filed for the assignee):

goldMedal Stephen Charles Benz (32 out of 57 patents)

silverMedal Shahrooz Rabizadeh (31 out of 86 patents)

bronzeMedal Patrick Soon-Shiong (25 out of 476 patents)

4.  Kayvan R Niazi (16 out of 101 patents)

5.  John Zachary Sanborn (15 out of 63 patents)

6.  Andrew Nguyen (15 out of 183 patents)

7.  Bing Song (14 out of 79 patents)

8.  Christopher W Szeto (13 out of 14 patents)

9.  Liudmila A Beziaeva (11 out of 11 patents)

10.  Charles Joseph Vaske (9 out of 33 patents)

11.  Mustafa Jaber (9 out of 22 patents)

12.  Nicholas James Witchey (5 out of 160 patents)

13.  Kamil A Wnuk (5 out of 47 patents)

14.  Rahul Chaturvedi (4 out of 19 patents)

15.  Paul Weingarten (4 out of 10 patents)


Core Competencies:
HLA Tissue Matching
Deep Learning Models
Tumor Evaluation
Viral Neoepitopes
Synthetic Genomic Variants
Digital Histopathology
Cancer Score
Immunotherapy Markers
RNA Stabilization
Genomic Analysis
Adaptive Immunotherapy
Pathology Image Analysis

66 patents:

1. 12676208 - TUMOR ANTIGENICITY PROCESSING AND PRESENTATION (2026-07-07),
2. 12614612 - HLA tissue matching and methods therefor (2026-04-28),
3. 12518214 - Distributed machine learning systems including generation of synthetic data (2026-01-06),
4. 12487240 - Tumor HLA mutation versus matched normal HLA (2025-12-02),
5. 12412639 - Method of characterizing a tumor based on an immune gene expression signature in regulatory T cell (Treg)-enriched tumor samples (2025-09-09),
6. 12406366 - Real-time whole slide pathology image cell counting (2025-09-02),
7. 12404490 - AGGF1 immunogenic compositions (2025-09-02),
8. 12224066 - Deep learning models for region of interest determination (2025-02-11),
9. 12224064 - Deep learning models for tumor evaluation (2025-02-11),
10. 12205678 - Genome explorer system to process and present nucleotide variations in genome sequence data (2025-01-21),
11. 12205033 - Weakly supervised learning with whole slide images (2025-01-21),
12. 12195808 - Dynamic changes in circulating free RNA of neural tumors (2025-01-14),
13. 12170142 - Classification based on characterization analysis methods and systems (2024-12-17),
14. 12094574 - Difference-based genomic identity scores (2024-09-17),
15. 12080382 - Viral neoepitopes and uses thereof (2024-09-03),
Company Overview
Nantomics, LLC, based in Culver City, CA, specializes in advancing cancer immunotherapy through innovative technologies. The company focuses on HLA tissue matching and the development of deep learning models to enhance tumor evaluation. By leveraging synthetic genomic variants and viral neoepitopes, Nantomics aims to improve patient outcomes in cancer treatment. Their expertise also extends to digital histopathology and the identification of immunotherapy markers, positioning them at the forefront of personalized cancer care.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Nantomics, LLC USPTO Patent Assignee Logo
66 Patents

#5 in Culver City, CA

#1,289 in California

#5,530 in US

#11,167 in the World

Culver City, CA (US)
Culver City, CA, United States of America

Nantomics, LLC

Forward Citations = 147

40 inventors:

goldMedal Stephen Charles Benz (32 out of 57 patents)

silverMedal Shahrooz Rabizadeh (31 out of 86 patents)

bronzeMedal Patrick Soon-Shiong (25 out of 476 patents)

4.  Kayvan R Niazi (16 out of 101 patents)

5.  John Zachary Sanborn (15 out of 63 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nantomics, LLC. Retrieved from https://idiyas.com/company/nantomics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…